Epigenetic Disruption of Histone Deacetylase-2 Accelerated Apoptotic Signaling and Retarded Malignancy in Gastric Cells

References

• Kanwal R , Gupta S . Epigenetics and cancer. J. Appl. Physiol. 109, 598–605 (2010).
   PubMed Web of Science ®Google Scholar
• McClure JJ , Li X , Chou CJ . Advances and challenges of HDAC inhibitors in cancer therapeutics. Elsevier Inc. 138, 183–211 (2018).
   Google Scholar
• Li Y , Seto E . HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb. Perspect. Med. 6(10), 1–34 (2016).
   Web of Science ®Google Scholar
• Souza C , Chatterji B . HDAC inhibitors as novel anti-cancer therapeutics. Recent Pat. Anticancer Drug Discov. 10(2), 145–162 (2015).
   PubMed Web of Science ®Google Scholar
• Li H , Yang Y , Hong W , Huang M , Wu M , Zhao X . Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduct. Target Ther. 5(1), 1–23 (2020).
   PubMed Web of Science ®Google Scholar
• Hosseini SA , Salehifard Jouneghani A , Ghatrehsamani M , Yaghoobi H , Elahian F , Mirzaei SA . CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy. Int. J. Biol. Macromol. 223(PA), 732–754 (2022).
   PubMedGoogle Scholar
• Liu AN , Zhu ZH , Chang SJ , Hang XS . Twist expression associated with the epithelial-mesenchymal transition in gastric cancer. Mol. Cell. Biochem. 367(1–2), 195–203 (2012).
   PubMed Web of Science ®Google Scholar
• Peinado H , Ballestar E , Esteller M , Cano A . Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell Biol. 24(1), 306–319 (2004).
   PubMed Web of Science ®Google Scholar
• Lin CL , Tsai ML , Lin CY et al. HDAC1 and HDAC2 double knockout triggers cell apoptosis in advanced thyroid cancer. Int. J. Mol. Sci. 20(2), 1–13 (2019).
   Web of Science ®Google Scholar
• Tang W , Zhou W , Xiang L et al. The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer. Nat. Commun. 10(1), 1–17 (2019).
   PubMedGoogle Scholar
• Cui H , Yu W , Yu M et al. GPR126 regulates colorectal cancer cell proliferation by mediating HDAC2 and GLI2 expression. Cancer Sci. 112(5), 1798–1810 (2021).
   PubMed Web of Science ®Google Scholar
• Huang W , Chen J , Liu X et al. MIER3 induces epithelial–mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail. Exp. Cell. Res. 406(1), 1–12 (2021).
   Web of Science ®Google Scholar
• Qi ZP , Yalikong A , Zhang JW et al. HDAC2 promotes the EMT of colorectal cancer cells and via the modular scaffold function of ENSG00000274093.1. J. Cell. Mol. Med. 25(2), 1190–1197 (2021).
   PubMed Web of Science ®Google Scholar
• Green MR , Sambrook J . Isolation of DNA fragments from polyacrylamide gels by the crush and soak method. Cold Spring Harb. Protoc. 2019(2), 143–146 (2019).
   Google Scholar
• Korzyńska A , Zychowicz M . A method of estimation of the cell doubling time on basis of the cell culture monitoring data. Biocybern. Biomed. Eng. 28(4), 75–82 (2008).
   Web of Science ®Google Scholar
• Crowley LC , Christensen ME , Waterhouse NJ . Measuring survival of adherent cells with the colony-forming assay. Cold Spring Harb. Protoc. 2016(8), 721–724 (2016).
   Google Scholar
• Ogura Y , Parsons WH , Kamat SS , Cravatt BF . Assaying cell cycle status using flow cytometry Kang. Physiol. Behav. 176(10), 139–148 (2017).
   PubMedGoogle Scholar
• Sebaugh JL . Guidelines for accurate EC50/IC50 estimation. Pharm. Stat. 10(2), 128–134 (2011).
   PubMed Web of Science ®Google Scholar
• Lakshmanan I , Batra S . Protocol for apoptosis assay by flow cytometry using annexin V staining method. Bio-Protocol 3(6), 1–4 (2013).
   Google Scholar
• Jafari M , Rahimi N , Jami MS , Hashemzadeh Chaleshtori M , Elahian F , Mirzaei SA . Silencing of α-N-acetylgalactosaminidase in the gastric cancer cells amplified cell death and attenuated migration, while the multidrug resistance remained unchanged. Cell. Biol. Int. 46(2), 255–264 (2022).
   PubMed Web of Science ®Google Scholar
• Pijuan J , Barceló C , Moreno DF et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Front. Cell. Dev. Biol. 7(JUN), 1–16 (2019).
   PubMedGoogle Scholar
• Mansouri M , Mirzaei SA , Lage H , Mousavi SS , Elahian F . The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells. Biochimie 99(1), 71–76 (2014).
   PubMedGoogle Scholar
• Heidari R , Khosravian P , Mirzaei SA , Elahian F . siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells. Sci. Rep. 11(1), 1–14 (2021).
   PubMed Web of Science ®Google Scholar
• Klieser E , Swierczynski S , Mayr C et al. Role of histone deacetylases in pancreas: implications for pathogenesis and therapy. World J. Gastrointest. Oncol. 7(12), 473–483 (2015).
   PubMed Web of Science ®Google Scholar
• Shetty MG , Pai P , Deaver RE , Satyamoorthy K , Babitha KS . Histone deacetylase 2 selective inhibitors: a versatile therapeutic strategy as next generation drug target in cancer therapy. Pharmacol. Res. 170, 105695 (2021).
   PubMed Web of Science ®Google Scholar
• Von Burstin J , Eser S , Paul MC et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology 137(1), 361–371.e5 (2009).
   PubMed Web of Science ®Google Scholar
• Sun J , Piao J , Li N , Yang Y , Kim KY , Lin Z . Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer. FEBS J. 287(10), 2118–2133 (2020).
   PubMed Web of Science ®Google Scholar
• Peng S , Zhao S , Yan F et al. HDAC2 selectively regulates FOXO3a-mediated gene transcription during oxidative stress-induced neuronal cell death. J. Neurosci. 35(3), 1250–1259 (2015).
   PubMed Web of Science ®Google Scholar
• Fei G , Ebert MPA , Mawrin C et al. Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives. Eur. J. Gastroenterol. Hepatol. 14(3), 297–303 (2002).
   PubMed Web of Science ®Google Scholar
• Yusufu A , Tuerdi R , Redati D , Rehemutula A , Zhao ZL , Wang HJ . Expression and clinical correlation of Survivin and PTEN in gastric cancer patients. Oncol. Lett. 20(6), 1–9 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang LL , Liu J , Lei S , Zhang J , Zhou W , Yu HG . PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression. Cell. Signal. 26(5), 1011–1020 (2014).
   PubMed Web of Science ®Google Scholar
• Lu XX , Cao LY , Chen X , Xiao J , Zou Y , Chen Q . PTEN inhibits cell proliferation, promotes cell apoptosis, and induces cell cycle arrest via downregulating the PI3K/AKT/ hTERT pathway in lung adenocarcinoma A549 cells. Biomed. Res. Int. 2016, 1–8 (2016).
   Web of Science ®Google Scholar
• Zhang G , Gan YH . Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN. Oncol. Rep. 38(5), 2657–2666 (2017).
   PubMed Web of Science ®Google Scholar
• Gan YH , Zhang S . PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. Oral Oncol. 45(10), e150–e154 (2009).
   PubMed Web of Science ®Google Scholar
• Qian J , Luo Y , Gu X , Zhan W , Wang X . Twist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1. PLOS ONE 8(10), 1–7 (2013).
   Web of Science ®Google Scholar
• Zhang Y , Cai X , Chai N et al. SIRT1 is reduced in gastric adenocarcinoma and acts as a potential tumor suppressor in gastric cancer. Gastrointest. Tumors. 2(3), 109–123 (2015).
   Google Scholar
• Dong G , Wang B , An Y et al. SIRT1 suppresses the migration and invasion of gastric cancer by regulating ARHGAP5 expression. Cell Death Dis. 9(10), 1–12 (2018).
   PubMedGoogle Scholar
• Özcan Ö , Belli AK , Çetin ES et al. Upregulation of SIRT1 gene in gastric adenocarcinoma. Turkish J. Gastroenterol. 30(4), 326–330 (2019).
   PubMed Web of Science ®Google Scholar
• An Y , Wang B , Wang X , Dong G , Jia J , Yang Q . SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop. Cell. Death Dis. 11(2), 1–14 (2020).
   PubMed Web of Science ®Google Scholar
• Wang L , Tan RZ , Zhang ZX et al. Association between Twist and multidrug resistance gene-associated proteins in Taxol®-resistant MCF-7 cells and a 293 cell model of twist overexpression. Oncol. Lett. 15(1), 1058–1066 (2018).
   PubMed Web of Science ®Google Scholar
• Gholamian N , Seyed D , Mirzaei A , Elahian F . Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness. Inflammopharmacology 29(1), 49–74 (2021).
   PubMed Web of Science ®Google Scholar
• Duan H , Heckman CA , Boxer LM . Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol. Cell. Biol. 25(5), 1608–19 (2005).
   PubMed Web of Science ®Google Scholar
• Ramakrishnan VG , Miller KC , Macon EP et al. Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma. Haematologica 104(10), 2061–2074 (2019).
   PubMed Web of Science ®Google Scholar